Ryplazim 68.8 mg/1
plasminogen · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Kedrion Biopharma, Inc.
Ryplazim is a injection, powder, lyophilized, for solution containing plasminogen at 68.8 mg/1, taken intravenous. Manufactured by Kedrion Biopharma, Inc..
Key Facts
- Brand Name
- Ryplazim
- Generic Name
- plasminogen
- NDC Code (Product)
70573-099- Manufacturer
- Kedrion Biopharma, Inc.
- Strength
- 68.8 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125659
- Marketing Start
- 06/04/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Ryplazim used for?
Ryplazim contains plasminogen. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Ryplazim a controlled substance?
Ryplazim is not classified as a controlled substance by the DEA.
What is the generic name for Ryplazim?
The generic name for Ryplazim is plasminogen. There are no other listed brand versions of plasminogen.
What is the NDC code for Ryplazim 68.8 mg/1?
The NDC (National Drug Code) for Ryplazim 68.8 mg/1 is 70573-099, listed by Kedrion Biopharma, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)